The multiomics services market size has grown exponentially in recent years. It will grow from $1.42 billion in 2025 to $1.71 billion in 2026 at a compound annual growth rate (CAGR) of 20.4%. The growth in the historic period can be attributed to growth in genomics and proteomics research activities, expansion of academic and clinical research funding, increasing availability of high-throughput sequencing technologies, rising collaboration between research institutions, advancements in bioinformatics tools.
The multiomics services market size is expected to see exponential growth in the next few years. It will grow to $3.56 billion in 2030 at a compound annual growth rate (CAGR) of 20.1%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, rising pharmaceutical investment in systems biology, expansion of multiomics applications in drug discovery, growing use of ai-based biological data interpretation, increasing demand for personalized therapeutic development. Major trends in the forecast period include increasing adoption of integrated multiomics analysis platforms, rising demand for single-cell multiomics services, growing use of data-driven biological insights, expansion of cloud-based omics data integration, enhanced focus on translational research applications.
The growing adoption of personalized medicine is expected to drive the growth of the multiomics services market in the coming years. Personalized medicine is a healthcare model that uses information about an individual’s genes and lifestyle to tailor treatments and care to their specific needs. Its increasing adoption is driven by the demand for health technologies that provide real-time monitoring and treatment plans customized to each person’s biology. Multiomics services support personalized medicine by integrating diverse biological data - such as genomics, transcriptomics, proteomics, and metabolomics - to deliver a comprehensive view of an individual’s health profile, enabling precise diagnosis, treatment, and disease prevention strategies. For example, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, up from 12 approvals in 2022. As a result, the rising adoption of personalized medicine is contributing to the growth of the multiomics services market.
Leading companies in the multiomics services market are focusing on innovative approaches, such as 3D genome mapping, to advance understanding of gene regulation, disease mechanisms, and personalized treatment strategies. 3D genome mapping involves determining the three-dimensional spatial organization of the genome within a cell’s nucleus. For instance, in January 2025, Enhanc3D Genomics, a UK-based biotechnology company, launched a suite of 3D multi-omics solutions to accelerate and improve the precision of drug discovery. The platform integrates genome-wide regulatory interaction data with multi-omics profiles in a single assay, providing comprehensive insights into gene regulation. Its proprietary Promoter Capture Hi-C technology enables precise mapping of long-range interactions between regulatory elements and target genes, including non-coding regions. The platform’s modular components - GenLinkConnect, GenLinkResponse, and GenLinkProfile - support SNP-to-gene linkage, drug response analysis, and cell-specific regulatory profiling, respectively, while the GenLinkHub software provides intuitive 3D visualization, data management, and quality control to help researchers interpret complex datasets and accelerate drug discovery.
In June 2025, Bruker Corporation, a US-based scientific instruments and analytical solutions provider, acquired Biocrates Life Sciences AG for an undisclosed sum. Through this acquisition, Bruker aims to strengthen its multiomics strategy by integrating Biocrates’ advanced metabolomics and lipidomics technologies with its existing proteomics workflows. Biocrates Life Sciences AG is an Austria-based biotechnology company specializing in multiomics services.
Major companies operating in the multiomics services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, QIAGEN NV, Azenta Inc., BGI Group, 10x Genomics Inc., BioLegend Inc., Oxford Nanopore Technologies Plc, NanoString Technologies Inc., Pacific Biosciences Inc., Metware Biotechnology Inc., Source BioScience Limited, CD Genomics Inc., Psomagen Inc., Creative Proteomics, Sapient Bioanalytics LLC, Dalton Bioanalytics Inc., Clinical Microbiomics A/S.
North America was the largest region in the multiomics services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the multiomics services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the multiomics services market by increasing costs of imported sequencing instruments, reagents, consumables, and advanced analytical software used in genomics, proteomics, and metabolomics workflows. Research institutions and pharmaceutical companies in North America and Europe are most affected due to dependence on imported laboratory technologies, while Asia-Pacific faces cost pressure on service scalability. These tariffs are increasing operational costs and extending project timelines. However, they are also encouraging regional reagent manufacturing, localized service delivery models, and domestic development of multiomics platforms.
The multiomics services market research report is one of a series of new reports that provides multiomics services market statistics, including multiomics services industry global market size, regional shares, competitors with a multiomics services market share, detailed multiomics services market segments, market trends and opportunities, and any further data you may need to thrive in the multiomics services industry. This multiomics services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Multiomics services involve a comprehensive approach in biological research that integrates multiple omics data types, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics. This approach enables the combined analysis of different biological layers to achieve a holistic understanding of complex biological systems.
The primary types of multiomics services include single-cell multiomics and bulk multiomics. Single-cell multiomics integrates and analyzes multiple molecular data types - such as genomics, transcriptomics, proteomics, and epigenomics - at the level of individual cells. It is applied across various areas, including biomarker discovery, drug discovery and development, synthetic biology, and others, and serves end-users such as academic and research institutions, pharmaceutical and biotechnology companies, and other organizations.
The multiomics services market includes revenues earned by entities by providing services such as genomics analysis, transcriptomics profiling, proteomics services, metabolomics analysis, and epigenomics studies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The multiomics services market size is expected to see exponential growth in the next few years. It will grow to $3.56 billion in 2030 at a compound annual growth rate (CAGR) of 20.1%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, rising pharmaceutical investment in systems biology, expansion of multiomics applications in drug discovery, growing use of ai-based biological data interpretation, increasing demand for personalized therapeutic development. Major trends in the forecast period include increasing adoption of integrated multiomics analysis platforms, rising demand for single-cell multiomics services, growing use of data-driven biological insights, expansion of cloud-based omics data integration, enhanced focus on translational research applications.
The growing adoption of personalized medicine is expected to drive the growth of the multiomics services market in the coming years. Personalized medicine is a healthcare model that uses information about an individual’s genes and lifestyle to tailor treatments and care to their specific needs. Its increasing adoption is driven by the demand for health technologies that provide real-time monitoring and treatment plans customized to each person’s biology. Multiomics services support personalized medicine by integrating diverse biological data - such as genomics, transcriptomics, proteomics, and metabolomics - to deliver a comprehensive view of an individual’s health profile, enabling precise diagnosis, treatment, and disease prevention strategies. For example, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, up from 12 approvals in 2022. As a result, the rising adoption of personalized medicine is contributing to the growth of the multiomics services market.
Leading companies in the multiomics services market are focusing on innovative approaches, such as 3D genome mapping, to advance understanding of gene regulation, disease mechanisms, and personalized treatment strategies. 3D genome mapping involves determining the three-dimensional spatial organization of the genome within a cell’s nucleus. For instance, in January 2025, Enhanc3D Genomics, a UK-based biotechnology company, launched a suite of 3D multi-omics solutions to accelerate and improve the precision of drug discovery. The platform integrates genome-wide regulatory interaction data with multi-omics profiles in a single assay, providing comprehensive insights into gene regulation. Its proprietary Promoter Capture Hi-C technology enables precise mapping of long-range interactions between regulatory elements and target genes, including non-coding regions. The platform’s modular components - GenLinkConnect, GenLinkResponse, and GenLinkProfile - support SNP-to-gene linkage, drug response analysis, and cell-specific regulatory profiling, respectively, while the GenLinkHub software provides intuitive 3D visualization, data management, and quality control to help researchers interpret complex datasets and accelerate drug discovery.
In June 2025, Bruker Corporation, a US-based scientific instruments and analytical solutions provider, acquired Biocrates Life Sciences AG for an undisclosed sum. Through this acquisition, Bruker aims to strengthen its multiomics strategy by integrating Biocrates’ advanced metabolomics and lipidomics technologies with its existing proteomics workflows. Biocrates Life Sciences AG is an Austria-based biotechnology company specializing in multiomics services.
Major companies operating in the multiomics services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, QIAGEN NV, Azenta Inc., BGI Group, 10x Genomics Inc., BioLegend Inc., Oxford Nanopore Technologies Plc, NanoString Technologies Inc., Pacific Biosciences Inc., Metware Biotechnology Inc., Source BioScience Limited, CD Genomics Inc., Psomagen Inc., Creative Proteomics, Sapient Bioanalytics LLC, Dalton Bioanalytics Inc., Clinical Microbiomics A/S.
North America was the largest region in the multiomics services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the multiomics services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the multiomics services market by increasing costs of imported sequencing instruments, reagents, consumables, and advanced analytical software used in genomics, proteomics, and metabolomics workflows. Research institutions and pharmaceutical companies in North America and Europe are most affected due to dependence on imported laboratory technologies, while Asia-Pacific faces cost pressure on service scalability. These tariffs are increasing operational costs and extending project timelines. However, they are also encouraging regional reagent manufacturing, localized service delivery models, and domestic development of multiomics platforms.
The multiomics services market research report is one of a series of new reports that provides multiomics services market statistics, including multiomics services industry global market size, regional shares, competitors with a multiomics services market share, detailed multiomics services market segments, market trends and opportunities, and any further data you may need to thrive in the multiomics services industry. This multiomics services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Multiomics services involve a comprehensive approach in biological research that integrates multiple omics data types, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics. This approach enables the combined analysis of different biological layers to achieve a holistic understanding of complex biological systems.
The primary types of multiomics services include single-cell multiomics and bulk multiomics. Single-cell multiomics integrates and analyzes multiple molecular data types - such as genomics, transcriptomics, proteomics, and epigenomics - at the level of individual cells. It is applied across various areas, including biomarker discovery, drug discovery and development, synthetic biology, and others, and serves end-users such as academic and research institutions, pharmaceutical and biotechnology companies, and other organizations.
The multiomics services market includes revenues earned by entities by providing services such as genomics analysis, transcriptomics profiling, proteomics services, metabolomics analysis, and epigenomics studies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Multiomics Services Market Characteristics
3. Multiomics Services Market Supply Chain Analysis
4. Global Multiomics Services Market Trends and Strategies
5. Multiomics Services Market Analysis of End Use Industries
7. Global Multiomics Services Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Multiomics Services Total Addressable Market (TAM) Analysis for the Market
9. Multiomics Services Market Segmentation
10. Multiomics Services Market Regional and Country Analysis
11. Asia-Pacific Multiomics Services Market
12. China Multiomics Services Market
13. India Multiomics Services Market
14. Japan Multiomics Services Market
15. Australia Multiomics Services Market
16. Indonesia Multiomics Services Market
17. South Korea Multiomics Services Market
18. Taiwan Multiomics Services Market
19. South East Asia Multiomics Services Market
20. Western Europe Multiomics Services Market
21. UK Multiomics Services Market
22. Germany Multiomics Services Market
23. France Multiomics Services Market
24. Italy Multiomics Services Market
25. Spain Multiomics Services Market
26. Eastern Europe Multiomics Services Market
27. Russia Multiomics Services Market
28. North America Multiomics Services Market
29. USA Multiomics Services Market
30. Canada Multiomics Services Market
31. South America Multiomics Services Market
32. Brazil Multiomics Services Market
33. Middle East Multiomics Services Market
34. Africa Multiomics Services Market
36. Multiomics Services Market Competitive Landscape and Company Profiles
37. Multiomics Services Market Other Major and Innovative Companies
40. Multiomics Services Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Multiomics Services Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses multiomics services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for multiomics services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The multiomics services market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Single-Cell Multiomics; Bulk Multiomics2) By Application: Biomarker Discovery; Drug Discovery And Development; Synthetic Biology; Other Applications
3) By End Users: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End Users
Subsegments:
1) By Single-Cell Multiomics: Single-Cell Genomics Services; Single-Cell Transcriptomics Services; Single-Cell Proteomics Services; Single-Cell Epigenomics Services2) By Bulk Multiomics: Genomics And Transcriptomics Integration Services; Genomics And Proteomics Integration Services; Transcriptomics And Proteomics Integration Services; Epigenomics And Transcriptomics Integration Services
Companies Mentioned: Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; Bruker Corporation; QIAGEN NV; Azenta Inc.; BGI Group; 10x Genomics Inc.; BioLegend Inc.; Oxford Nanopore Technologies Plc; NanoString Technologies Inc.; Pacific Biosciences Inc.; Metware Biotechnology Inc.; Source BioScience Limited; CD Genomics Inc.; Psomagen Inc.; Creative Proteomics; Sapient Bioanalytics LLC; Dalton Bioanalytics Inc.; Clinical Microbiomics A/S.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Multiomics Services market report include:- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- PerkinElmer Inc.
- Bruker Corporation
- QIAGEN NV
- Azenta Inc.
- BGI Group
- 10x Genomics Inc.
- BioLegend Inc.
- Oxford Nanopore Technologies Plc
- NanoString Technologies Inc.
- Pacific Biosciences Inc.
- Metware Biotechnology Inc.
- Source BioScience Limited
- CD Genomics Inc.
- Psomagen Inc.
- Creative Proteomics
- Sapient Bioanalytics LLC
- Dalton Bioanalytics Inc.
- Clinical Microbiomics A/S.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.71 Billion |
| Forecasted Market Value ( USD | $ 3.56 Billion |
| Compound Annual Growth Rate | 20.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
